Who We Are

HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), Montreal (Dorval, Quebec) and Philadelphia (Rosemont, Pennsylvania).  We source our products from the drug’s originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada’s regulations.

Our Goal/Our Mission

HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycle during and post exclusivity, providing access to treatments critical to Health Care Providers, patients and their caregivers with the brand names they trust.